OHSU in the news

How CAR-T immunotherapy improves quality of life after cancer treatment

Healthline March 18, 2020
In an article describing how CAR-T immunotherapy can help improve quality of life after cancer treatment, Richard Maziarz, M.D., says: “Many patients with this advanced level of disease become depressed and withdraw, but here patients reported improved functional status, physical capabilities, and ability to interact with people.”

Nike, trio of top execs, donate $15 million to virus aid efforts

The Oregonian March 18, 2020
Nike leaders, including Phil and Penny Knight, donate $7 million to support OHSU’s COVID-19 response. Danny Jacobs, M.D., M.P.H., F.A.C.S., says: “People across the state have come together to face this challenge collaboratively, and this support will have a profound impact on our ability to meet it”.

Switching TNF inhibitors rare, delayed in AS despite inefficacy

Healio March 17, 2020
Atul Deodhar, M.D., reports 22% of patients with the chronic joint inflammation condition ankylosing spondylitis (AS) discontinue treatment with tumor necrosis factor (TNF) inhibitors after a year due to drug inefficacy or adverse events.
See more stories